ERICKA CAMPBELL: Open Payments
NPI 1629834973 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 17 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,127 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $378 |
| Sage Therapeutics, LLC | 2 | $175 |
| Organogenesis Inc. | 1 | $174 |
| Vertex Pharmaceuticals Incorporated | 2 | $167 |
| Janssen Biotech, Inc. | 1 | $140 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Neurocrine BioSciences, Inc. | 1 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $91 |
Products named: APLIGRAF, TREMFYA, NEFFY, VOQUEZNA, INGREZZA, TZIELD, SPRAVATO, Arikayce.
Industry payments across MD — which companies pay providers there.
